Mexico is the second largest pharmaceutical market in Latin America and an important high-tech medicine producer. The Mexican companies at CFM are well positioned to seize expansion opportunities as their reach in almost 50 countries derives from advanced technology, innovation capacity, a wide range of therapeutic products and a high level of commitment and ethics to patients.
In 2020, the use of pharmaceutical products in Mexico had doubled in comparison to 2010. The mexican pharmaceutical industry is focused on research, development, production and trade of chemical and biopharmaceutical products used for preventing and treating illness -such as antibiotics, anti-inflammatories, cancer treatments, vaccines, anti serums, vitamins- and pharmaceutical applications for veterinary use, among others.
CFM, through its six laboratories, incorporates:
An investment of